Gene transfer of the co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent

Scandinavian Journal of Immunology

Volumn 50, Issue 3, 1999, Pages 242-249

  Jung, D ^a   Hilmes, C ^a   Knuth, A ^b   Jaeger, E ^b   Huber, C ^a   Seliger, Barbara ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Nordwest Krankenhaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOGENICITY; KIDNEY CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CARCINOMA, RENAL CELL; CELL LINE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; KIDNEY NEOPLASMS; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032793723     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00588.x     Document Type: Article

References (50)

1. 1 Dubey C, Croft M. Accessory molecule regulation of naive CD4 T cell activation. Immunol Res 1996;15:114-25.
2. 2 Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191-212.
3. 3 Lenschow D, Walunas T, Bluestone J. CD28/B 7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-58.
4. 4 Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-80.
5. 5 Jenkins MK, Johnson JG. Molecules involved in T-cell costimulation. Curr Opin Immunol 1993;5:361-7.
6. 6 Azuma M, Ito D, Yagita H et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-9.
7. 7 Freeman GJ, Gribben JG, Boussiotis VA et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993;262:909-11.
8. 8 Chen L, Ashe S, Brady WA et al. Co-stimulation of anti-tumor immunity by the B7 counterreceptor for the T-lymphocyte molecules CD28 and CTLA-4. Cell 1992;71:1093-102.
9. 9 Linsley PS, Brady W, Grosmaire L et al. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 mRNA accumulation. J Exp Med 1991;173:721-30.
10. 10 Hathcock KS, Laszlo G, Pucillo C et al. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 1994;180:631-40.
11. 11 Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/ Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80: 707-18.
12. 12 Lanier LL, O'Fallon S, Somoza C et al. CD80 (B7) and CD86 (B7.2) provide similar co-stimulatory signals for T-cell proliferation, cytokine production and generation of CTL. J Immunol 1995;1:97-105.
13. 13 Tan P, Anasetti C, Hansen JA et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993;177:165-73.
14. 14 Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995;2:555-9.
15. 15 Harding FA, McArthur JG, Gross JA et al. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (London) 1992;356:607-9.
16. 16 Gimmi CD, Freeman GJ, Gribben JG et al. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993;90:6586-90.
17. 17 Boussiotis VA, Barber DL, Lee BJ et al. Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation. J Exp Med 1996;184:365-76.
18. 18 Essery G, Feldmann M, Lamp J. Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology 1988;64:413-7.
19. 19 Gajewski TF, Renauld JC, van Pel A et al. Costimulation with B7-1, IL-2 and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J Immunol 1995;154:5637-48.
20. 20 Seliger B, Maeurer M, Ferrrone S. TAP off - tumors on. Immunol Today 1997;18:292-9.
21. 21 Restifo NP, Esquivel F, Kawakami Y et al. Identification of human cancers deficient in antigen processing. J Exp Med 1993; 177:265-72.
22. 22 Attaya M, Jameson S, Martinez, CK et al. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 1992;355:647-9.
23. 23 Restifo NP, Spiess PJ, Karp SE et al. A non-immunogenic sarcoma transduced with the cDNA for interferon-gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capacity. J Exp Med 1992;175:1423-31.
24. 24 Talmage DW, Woolnough JA, Hemmingsen H et al. Activation of cytotoxic T cells by non-stimulating tumor cells and spleen factor(s). Proc Natl Acad Sci USA 1977;74:4610-4.
25. 25 Baskar S, Ostrand-Rosenberg S, Nahavi N et al. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major-histocompatibility-complex-class-II molecules. Proc Natl Acad Sci USA 1993;90:5687-90.
26. 26 Chen L, McGowan P, Ashe S et al. Tumor immunogenicity determines the effect of B7 co-stimulation on T-cell-mediated tumor immunity. J Exp Med 1994;179:523-32.
27. 27 Ramarathinam L, Castle M, Wu Y et al. T-cell costimulation by B7/ BB1 induces CD8 T-cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment and effector function of anti-tumor cells. J Exp Med 1994;179:1205-14.
28. 28 Chamberlain RS, Carroll MW, Bronte V et al. Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines. Cancer Res 1996;56:2832-6.
29. + T cells by B7-transfected melanoma cells. Science 1993;259:368-70.
30. 30 Yang S, Darrow TL, Seigier HF. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells. Cancer Res 1997;57:1561-8.
31. 31 Sulé-Suso J, Arienti F, Melani C et al. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes. Eur J Immunol 1995;25:2737-42.
32. 32 Fenton RT, Sznol M, Luster DG et al. A phase I trial of B7-transfected or parental lethally irradiated allogenic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen-presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. Human Gene Ther 1995;6:87-106.
33. 33 Wang Q, Redovan C, Tubbs R et al. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int J Cancer 1995;61:780-5.
34. 34 Rosenberg SA, Lotze MT, Muul LM et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987;316:879-97.
35. 35 Schendel DJ, Gansbacher B, Oberneder Ret al. Tumor-specific lysis of human renal-cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J Immunol 1993;151:4209-20.
36. + T-cell line. J Immunother 1992;11:1-11.
37. 37 Koo AS, Tso CL, Shimbukuro Tet al. Autologous tumor-specific cytotoxicity of tumor infiltrating lymphocytes derived from human renal cell carcinoma. J Immunother 1991;10:347-54.
38. 38 Bernhard H, Karbach J, Wölfel Tet al. Cellular immune response to human renal cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T lymphocytes. Int J Cancer 1994;59:1-6.
39. 39 Brouwenstijn N, Gaugler B, Krüse KM et al. Renal cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Int J Cancer 1996;68:177-82.
40. 40 Riberdy JM, Cresswell P. The antigen processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J Immunol 1992;148:2586-90.
41. 41 Brodsky FM, Parham P, Barn CJet al. Monoclonal antibodies for analysis of the HLA system. Immunol Rev 1979;47:342-67.
42. 42 Cayeux S, Beck C, Aicher Aet al. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines. Eur J Immunol 1995;24:2325-31.
43. 43 Kubin M, Kamoun M, Trinchieri G. Interleukin-12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 1994;180:211-22.
44. 44 Bain C, Merrouche Y, Puisieux Iet al. B7-1 gene transduction of human renal cell carcinoma cell lines restores the proliferative response and cytotoxic function of allogeneic T cell. Int J Cancer 1996;67:769-76.
45. 45 Damle NK, Klussman K, Linsley PS, Aruffo A, Ledbetter JA. Differential regulatory effects of intracellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J Immunol 1992;149:2541-8.
46. 46 Ghiotto-Rageneau M, Battifora M, Truneh A, Waterfield MD, Olive D. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T-cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production. Eur J Immunol 1996;26: 34-41.
47. 47 Freeman GJ, Boussiotis VA, Anumanthan A et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995;2:523-32.
48. 48 Racke MK, Scott DE, Quigley L et al. Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyclitis. J Clin Invest 1995;96:2195-203.
49. 49 Borriello F, Sethna MP, Boyd Det al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997;6:303-13.
50. 50 Peng X, Remacle JE, Kasran A, Huylebroeck D, Ceuppens JL. IL-12 up-regulates CD40 ligand (CD154) expresson on human T cells. J Immunol 1998;160:1166-72.